2019 Publications

2019

Jain Rahi and Rao Bakul (2019) “Role of laboratory services in primary health center (PHC) outpatient department performance: An Indian case study”, Primary Health Care Research & Development, 20 (e112), 1-7.

Jain Rahi, Rao Bakul and Mishra Satanand (2019) “Development of village system model for predicting and comparing the different interventions success”, Current Science, 117(7), 1189-1194.

Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia.Puckrin R, Atenafu EG, Claudio JO, Chan S, Gupta V, Maze D, McNamara C, Murphy T, Shuh AC, Yee K, Sibai H, Minden MD, Wei C, Stockley T, Kamel-Reid S, Schimmer AD.Haematologica. 2020 Jan 2:haematol.2019.235721. doi: 10.3324/haematol.2019.235721.

Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study.  Khoja L, Atenafu EG, Suciu S, Leyvraz S, Sato T, Marshall E, Keilholz U, Zimmer L, Patel SP, Piperno-Neumann S, Piulats J, Kivelä TT, Pfoehler C, Bhatia S, Huppert P, Van Iersel LBJ, De Vries IJM, Penel N, Vogl T, Cheng T, Fiorentini G, Mouriaux F, Tarhini A, Patel PM, Carvajal R, Joshua AM.Ann Oncol. 2019 Aug 1;30(8):1370-1380. 

Impact of central nervous system involvement in AML on outcomes after allotransplant and utility of pretransplant cerebrospinal fluid assessment.Prem S, Atenafu EG, Avena J, Bautista R, Law A, Lam W, Michelis FV, Kim DDH, Viswabandya A, Lipton JH, Mattsson J, Kumar R.Eur J Haematol. 2019 Nov;103(5):483-490.

Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on Surveillance.Hamilton RJ, Nayan M, Anson-Cartwright L, Atenafu EG, Bedard PL, Hansen A, Chung P, Warde P, Sweet J, O'Malley M, Sturgeon J, Jewett MAS.J Clin Oncol. 2019 Aug 1;37(22):1919-1926.

Phenotypic Profiling of Circulating Tumor Cells in Metastatic Prostate Cancer Patients Using Nanoparticle-Mediated Ranking.Green BJ, Nguyen V, Atenafu E, Weeber P, Duong BTV, Thiagalingam P, Labib M, Mohamadi RM, Hansen AR, Joshua AM, Kelley SO.Anal Chem. 2019 Aug 6;91(15):9348-9355. 

Kuehneet al. Characterization and outcomes of patients enrolled to multiple phase 1 cancer trials. Cancer Chemother Pharmacol. 2019 Nov 8. [Epub ahead of print]

 

Hansen et al. Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC).Oncologist. 2019 Sep;24(9):1188-1194

Tanet al. Referrals to a Phase I Clinic and Trial Enrollment in the Molecular Screening Era.Oncologist. 2019 Jul;24(7):e518-e525.

 

O'Kane et al. A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial.Br J Cancer. 2019 Jun;120(12):1113-1119. 

Planteet al.  FIGO 2018 stage IB2 (2-4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study.Int J Gynecol Cancer. 2019 Jun;29(5):969-975.

 

Kanjanapan et al. Hyperprogressive disease in early-phase immunotherapy trials: Clinical predictors and association with immune-related toxicities.Cancer. 2019 Apr 15;125(8):1341-1349.

Traverso, A., Kazmierski, M., Welch, M.L., Weiss, J.,Fiset, S., Foltz, W.D., Gladwish, A., Dekker, A., Jaffray, D., Wee, L. and Han, K., 2019. Sensitivity of radiomic features to inter-observer variability and image pre-processing in Apparent Diffusion Coefficient (ADC) maps of cervix cancer patients. Radiotherapy and Oncology.

 

 

Fiset, S., Welch, M.L., Weiss, J., Pintilie, M., Conway, J.L., Milosevic, M., Fyles, A., Traverso, A., Jaffray, D., Metser, U. and Xie, J., 2019. Repeatability and reproducibility of MRI-based radiomic features in cervical cancer. Radiotherapy and Oncology, 135, pp.107-114.

Pittman T. Too much fertilizer? An observational association between inputs at planting and crop yield on a Saskatchewan farming operation. Can J Plant Sci. Published online 2020:1-10. doi:10.1139/cjps-2019-0223

Espin-Garcia O, Croitoru K, Xu W. (2019). A finite mixture model for X-chromosomeassociation with an emphasis on microbiome data analysis. Genet Epidemiol. 43(4):427-439.doi: 10.1002/gepi.22190 [Highlighted as paper of the month in February 2019. https://twitter.com/genepisociety/status/1100017574631301122]

O'Kane GM, Liu G, Stockley TL, Shabir M, Zhang T, Law JH, Le LW, Sacher A, Shepherd FA, Bradbury PA, Leighl NB (2019). The presence and variant allele fraction of EGFR mutations in ctDNA and development of resistance. Lung Cancer131: 86-89.

 

Chen CI, Paul H, Le LW, Wei EN, Snitzler S, Wang T, Levina O, Kakar S, Lau A, Queau M, Johnston JB, Smith DA, Trudel S (2019). A phase 2 study of ofatumumab (Arzerra®) in combination with a pan-AKT inhibitor (afuresertib) in previously treated patients with chronic lymphocytic leukemia (CLL). Leuk Lymphoma 60(1): 92-100

Back page

UHN Princess Margaret Hospital